Effect of Shexiang Baoxin Pills on endothelial microparticles content in peripheral blood of patients with syndrome X

DENG Yifan; HE Shenghu; ZHANG Jing

doi:10.7619/jcmp.20210727

Journal of Clinical Medicine in Practice > 2021 > 25(11): 82-84, 88. > DOI: 10.7619/jcmp.20210727

DENG Yifan, HE Shenghu, ZHANG Jing. Effect of Shexiang Baoxin Pills on endothelial microparticles content in peripheral blood of patients with syndrome X[J]. Journal of Clinical Medicine in Practice, 2021, 25(11): 82-84, 88. DOI: 10.7619/jcmp.20210727

Citation:

PDF (622 KB)

Effect of Shexiang Baoxin Pills on endothelial microparticles content in peripheral blood of patients with syndrome X

DENG Yifan^{1, 2},
HE Shenghu²,
ZHANG Jing^2, ,

1.
Medical College of Yangzhou University, Yangzhou, Jiangsu, 225001
2.
Department of CardiovascularMedicine, Subei People's Hospital in Jiangsu Province, Yangzhou, Jiangsu, 225001

More Information

Received Date: February 21, 2021
Available Online: June 14, 2021
Published Date: June 14, 2021

Graphical Abstract

Abstract

Abstract

Objective To explore the effect of Shexiang Baoxin Pills on endothelial microparticles (EMPs) content in peripheral blood of patients with syndrome X.
Methods Totally 75 patients diagnosed as syndrome X were selected and content of EMPs in peripheral blood was detected after blood collection, and the content of EMPs was compared with healthy people. They were randomly divided into two groups, control group was treated with western medicines such as nitrates and β receptor blockers, while the study group was treated with Shexiang Baoxin Pills. The content of EMPs before and after treatment, the score of Seattle Angina Questionnaire and the incidence of adverse reactions were compared between the two groups.
Results The content of EMPs in peripheral blood of 75 patients in this study was (2.01±0.71)%, which was significantly higher than (0.50±0.34)% in the 71 healthy people (P < 0.05). After treatment, the EMPs content in the study group decreased significantly, and was also significantly lower than that in the control group (P < 0.05). After treatment, the score of Seattle Angina Questionnaire increased significantly in the study group, and was also significantly higher than that in the control group (P < 0.05). There was no significant difference in the ratio of patients with adverse reactions between the two groups (P>0.05).
Conclusion Shexiang Baoxin Pills can effectively reduce the content of EMPs in the peripheral blood of patients with syndrome X, positively regulate vascular endothelial function, relieve the related symptoms of patients, and cause less adverse reactions.

FullText(HTML)

References (15)

References

[1]	KEMP H G. Left ventricular function in patients with the anginal syndrome and normal coronary arteriograms[J]. Am J Cardiol, 1973, 32(3): 375-376. doi: 10.1016/S0002-9149(73)80150-X
[2]	宋华. 麝香保心丸的药理研究与临床评价[J]. 中成药, 2002, 24(2): 131-133. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYA200202020.htm
[3]	张艳达, 隋汝杰, 赵健, 等. 冠状动脉微循环障碍: 非阻塞性冠心病潜在发病机制[J]. 第二军医大学学报, 2020, 41(3): 315-320. https://www.cnki.com.cn/Article/CJFDTOTAL-DEJD202003015.htm
[4]	VANHOUTTE P M, SHIMOKAWA H, FELETOU M, et al. Endothelial dysfunction and vascular disease-a 30th anniversary update[J]. Acta Physiol: Oxf, 2017, 219(1): 22-96. doi: 10.1111/apha.12646
[5]	GRESELE P, MOMI S, GUGLIELMINI G. Nitric oxide-enhancing or -releasing agents as antithrombotic drugs[J]. Biochem Pharmacol, 2019, 166: 300-312. doi: 10.1016/j.bcp.2019.05.030
[6]	WONG B W, MARSCH E, TREPS L, et al. Endothelial cell metabolism in health and disease: impact of hypoxia[J]. EMBO J, 2017, 36(15): 2187-2203. doi: 10.15252/embj.201696150
[7]	JACKSON A O, ZHANG J J, JIANG Z S, et al. Endothelial-to-mesenchymal transition: a novel therapeutic target for cardiovascular diseases[J]. Trends Cardiovasc Med, 2017, 27(6): 383-393. doi: 10.1016/j.tcm.2017.03.003
[8]	MYGIND N D, MICHELSEN M M, PENA A, et al. Coronary microvascular function and cardiovascular risk factors in women with angina pectoris and No obstructive coronary artery disease: the iPOWER study[J]. J Am Heart Assoc, 2016, 5(3): e003064.
[9]	LEITE A R, BORGES-CANHA M, CARDOSO R, et al. Novel biomarkers for evaluation of endothelial dysfunction[J]. Angiology, 2020, 71(5): 397-410. doi: 10.1177/0003319720903586
[10]	PAUDEL K R, PANTH N, KIM D W. Circulating endothelial microparticles: a key hallmark of atherosclerosis progression[J]. Scientifica: Cairo, 2016, 2016: 8514056. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811266/
[11]	CREA F, LANZA G A. Treatment of microvascular angina: the need for precision medicine[J]. Eur Heart J, 2016, 37(19): 1514-1516. doi: 10.1093/eurheartj/ehw021
[12]	史海龙, 王玉成, 樊莹莹, 等. 麝香保心丸治疗冠心病的网络药理学研究[J]. 时珍国医国药, 2017, 28(2): 320-323. https://www.cnki.com.cn/Article/CJFDTOTAL-SZGY201702023.htm
[13]	田静, 任雨贺, 刘淑莹, 等. 人参皂苷Re对心血管系统的药理作用研究进展[J]. 安徽农业科学, 2019, 47(6): 23-25. https://www.cnki.com.cn/Article/CJFDTOTAL-AHNY201906008.htm
[14]	ZHANG J, CUI Q, ZHAO Y, et al. Mechanism of angiogenesis promotion with Shexiang Baoxin Pills by regulating function and signaling pathway of endothelial cells through macrophages[J]. Atherosclerosis, 2020, 292: 99-111. doi: 10.1016/j.atherosclerosis.2019.11.005
[15]	白瑶, 许耀宗. 麝香保心丸治疗冠心病稳定性心绞痛的临床疗效及安全性研究[J]. 中药药理与临床, 2015, 31(1): 308-309. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYL201501125.htm

Cited By

Cited by

Periodical cited type(13)

1.	刘倩. 难治性胃食管反流病的中医疗法研究近况. 湖北中医杂志. 2023(11): 63-66 .
2.	杨超，陈莉丽，杨振斌. 方晓华抑木扶土法临床运用验案举隅. 中国民间疗法. 2022(14): 105-108 .
3.	郭丽，夏军权，刘晓桐. 难治性胃食管反流病中医药诊治研究进展. 光明中医. 2021(22): 3790-3793 .
4.	贾军峰，李文萍. 和胃降逆饮联合西药及针刺治疗残胃引起的反流性食管炎的疗效及对血清胃动素的影响. 中国中西医结合消化杂志. 2020(12): 944-948 .
5.	刘妍. 疏肝降逆汤联合中医特色护理治疗胃食管反流病效果研究. 药品评价. 2019(01): 44-46 .
6.	马雪梅. 和胃降逆汤加减联合奥美拉唑、枸橼酸莫沙必利治疗肝胃郁热型胃食管反流病的临床观察. 中国民间疗法. 2019(05): 55-56 .
7.	房晓娜. 和胃降逆汤加减治疗胃食管反流病肝胃郁热型临床观察. 实用中医药杂志. 2019(04): 413-414 .
8.	邓粉会. 自拟和胃降逆汤辅助西药治疗胃食管反流病相关性支气管哮喘疗效观察. 人人健康. 2019(24): 114-115 .
9.	黄太伟. 半夏厚朴汤加减治疗难治性胃食管反流病的疗效研究. 实用医技杂志. 2018(06): 625-626 .
10.	高钟. 泮托拉唑、香砂养胃丸、左金丸联用治疗胃食管反流病的效果观察. 中国社区医师. 2018(19): 102-103 .
11.	姚向东. 雷贝拉唑、莫沙必利与玄麦甘桔三联用药治疗咽喉反流疾病的临床疗效. 中国合理用药探索. 2018(02): 8-11 .
12.	王巧凤，王胜业. 和胃降逆汤加减治疗肝胃郁热型胃食管反流病疗效观察. 北方药学. 2018(11): 131 .
13.	王茜茜，李华岳. 加减乌梅丸方联合穴位针刺对胃食管反流病患者食管动力的影响. 中国中医药现代远程教育. 2018(23): 42-44 .

Other cited types(7)

Get Citation

PDF

XML

Article views (337) PDF downloads (9) Cited by(20)

Turn off MathJax

Article Contents

Abstract

References

Effect of Shexiang Baoxin Pills on endothelial microparticles content in peripheral blood of patients with syndrome X

Abstract

References

Cited by

Periodical cited type(13)

Other cited types(7)

Catalog

Export File

Citation

Format

Content